Chong Hwa Kim

Sejong General Hospital — South Korea

Medicine · Health Sciences

22h-index2.1kcitations91works7.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(24), Diabetes Management and Research(16), Pharmacology and Obesity Treatment(12), Diet and metabolism studies(11), Metabolism, Diabetes, and Cancer(10)

Publications87 total

Effects of Physical Activity on Medical Expenses among Individuals with Obesity in Korea: Insights from a Nationwide Study
Journal of Obesity & Metabolic Syndrome·2025Open Access
Effects of Physical Activity on Medical Expenses among Individuals with Obesity in Korea: Insights from a Nationwide Study
Journal of Obesity & Metabolic Syndrome·2025Open Access
Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52‐week, multicentre, randomized, placebo‐controlled, phase <scp>III</scp> clinical trial
Diabetes Obesity and Metabolism·2025· 1 citedOpen Access
2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association
Diabetes & Metabolism Journal·2025· 11 citedOpen Access
Clinical Characteristics and Epidemiology of Cardiovascular Autonomic Neuropathy in Peoples With Long-Standing Diabetes
Journal of Korean Medical Science·2025· 1 citedOpen Access
Evaluation of the efficacy and safety of controlled‐release phentermine/topiramate in adults with obesity in Korea: A randomized, double‐blind, placebo‐controlled, phase 4 trial ( <scp>QUEEN</scp> 's study)
Diabetes Obesity and Metabolism·2024· 2 citedOpen Access
Author response for "Evaluation of the efficacy and safety of controlled‐release phentermine/topiramate in adults with obesity in Korea: A randomized, double‐blind, placebo‐controlled, phase 4 trial (&lt;scp&gt;QUEEN&lt;/scp&gt;'s study)"
2024
Author response for "Evaluation of the efficacy and safety of controlled‐release phentermine/topiramate in adults with obesity in Korea: A randomized, double‐blind, placebo‐controlled, phase 4 trial (&lt;scp&gt;QUEEN&lt;/scp&gt;'s study)"
2024
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)
Endocrinology and Metabolism·2024· 5 citedOpen Access
2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
Diabetes & Metabolism Journal·2024· 61 citedOpen Access
Long‐term efficacy and safety of enavogliflozin in <scp>Korean</scp> people with type 2 diabetes: A 52‐week extension of a Phase 3 randomized controlled trial
Diabetes Obesity and Metabolism·2024· 3 citedOpen Access
Author response for "Long‐term efficacy and safety of enavogliflozin in &lt;scp&gt;Korean&lt;/scp&gt; people with type 2 diabetes: A 52‐week extension of a Phase 3 randomized controlled trial"
2024
Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study
Diabetes & Metabolism Journal·2024· 8 citedOpen Access
Position Statement on the Appropriateness and Significance of Adding the Glycated Hemoglobin Test to the National Health Examination
Journal of Korean Diabetes·2023· 1 citedOpen Access
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Diabetes & Metabolism Journal·2023· 117 citedOpen Access
Analysis of clinical phenotypes of neuropathic symptoms in patients with type 2 diabetes: A multicenter study
Journal of Diabetes Investigation·2022· 1 citedOpen Access
A Position Statement of the Utilization and Support Status of Continuous Glucose Monitoring in Korea
Journal of Korean Diabetes·2021· 6 citedOpen Access
Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society
Endocrinology and Metabolism·2021· 6 citedOpen Access
2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Diabetes & Metabolism Journal·2021· 221 citedOpen Access
2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea
Journal of Obesity & Metabolic Syndrome·2021· 317 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Tae Sun Park(10), In‐Kyung Jeong(8), Hyuk‐Sang Kwon(7), Tae Jung Oh(6), Jong Chul Won(6), Seon Mee Kang(5), Jae Hyun Kim(5), Jang Won Son(5), Nam Hoon Kim(5), You‐Bin Lee(5), Jae Hyeon Kim(5), Dae Jung Kim(5), Kyung Ae Lee(5), Jeong Hyun Lim(5), Yumie Rhee(5), Yong‐Ki Min(5), Seung Hun Lee(5), Eon Ju Jeon(4), Kyu Yeon Hur(4), Min Kyong Moon(4)